Dr. Thomas F. Imperiale, MD

  • Batesville, IN
  • Gastroenterologist
NPI1427012582
Medicare services, 2016
63
Part D claims, 2024
278
Publications
111
Clinical trials
3
Industry payments
$191,987
Practice address
321 Mitchell Avenue, Batesville, IN 47006
Practice phone
Call (812) 933-5125
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Margaret Mary Health Hospice

Hospice - Independent · Batesville, Indiana

See all 6 affiliations

Find Dr. Imperiale's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Thomas F. Imperiale is a gastroenterologist in Batesville, Indiana

Dr. Imperiale practices at Margaret Mary Health Hospice in Batesville, Indiana.

Dr. Imperiale's NPI, 1427012582, was assigned on April 14, 2006. Dr. Imperiale graduated from New York University School of Medicine in 1981. Dr. Imperiale holds Indiana license 01045693.

NPI and contact details
NPI enumeration date
April 14, 2006
NPI status
Active
Practice phone
(812) 933-5125
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
71
Medical school graduation
1981

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data

Dr. Thomas F. Imperiale practices at Margaret Mary Health Hospice in Batesville, Indiana

Dr. Imperiale's primary practice is Margaret Mary Health Hospice, at 321 Mitchell Avenue, Batesville, IN 47006 in Ripley County. The practice phone is (812) 933-5125.

  • Margaret Mary Health Hospice
    321 Mitchell Avenue, Batesville, IN 47006 · Ripley CountyPhone(812) 933-5125

Source: Dmand AI Affiliation Data

Dr. Thomas F. Imperiale is affiliated with 3 sites of care and 3 medical groups

Dr. Imperiale's primary practice is Margaret Mary Health Hospice in Batesville, Indiana. The medical group on file is Margaret Mary Health. Dmand AI also links Dr. Imperiale to 2 more group practices and clinics and 2 medical groups, each named with a free account.

See all 6 affiliations for Dr. Imperiale

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Thomas F. Imperiale's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Imperiale practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Margaret Mary Health HospiceAvailable with a free account
+2 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Imperiale practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Thomas F. Imperiale is one of 333 gastroenterologists in Indiana

Gastroenterology is Dr. Imperiale's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Imperiale is licensed in Indiana.

Specialties and state licenses

  • Gastroenterology, IndianaPrimaryLicense 01045693 · taxonomy 207RG0100X

Gastroenterologists near Dr. Imperiale

Counts of gastroenterologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Thomas F. Imperiale billed Medicare for 63 services in 2016

CMS data shows 63 Medicare services from Dr. Imperiale across 3 procedure codes in 2016. Medicare paid $5,537 for them.

Medicare services, 201663
Paid by Medicare$5,537
Procedure codes3

Dr. Imperiale's Medicare services by type, 2016

  1. Office and hospital visits33
  2. Surgery30

Where Dr. Imperiale's Medicare services took place, 2016

  • In an office3352%
  • In a facility3048%

Dr. Imperiale compared with the Indiana median for gastroenterologists, 2016

  • Dr. Imperiale
  • Indiana median
Medicare services
63vs 47187% below
Part D claims
192vs 42255% below

Medians across 330 gastroenterologists in Indiana with Dmand AI profiles that report each measure.

Dr. Imperiale's most billed Medicare procedure codes, 2016

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Imperiale

Need commercial claims for Dr. Imperiale?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Imperiale and other gastroenterologists in Indiana.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Thomas F. Imperiale's patients have a median age of 63

Across all payers, Dmand AI patient panel data puts Dr. Imperiale's median patient age at 63, with 69% women.

Dr. Imperiale's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 63

Patient panel by sex, all payers

  • Women69%
  • Men30%

Source: Dmand AI Patient Panel Data

Dr. Thomas F. Imperiale wrote 278 Medicare Part D claims in 2024

In 2024, Dr. Imperiale wrote 278 Medicare Part D claims for 67 patients. 74% of them were for generic drugs. CMS names the drug for 192 of them, across 11 drugs with 11 or more claims each, at $108,622 in total drug cost. In 2023, CMS named 140 claims across 8 drugs.

Part D claims, 2024278
Drugs named by CMS11
Total drug cost$108,622
Part D patients67

Dr. Imperiale's Part D claims by kind of drug, 2024

  • Generic207 claims74%
  • Brand-name71 claims26%

Dr. Imperiale's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Imperiale's Part D claims, 2024

  • Antibiotics6%16 of 278 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1402024: 19237%

Drugs named by CMS: 11 in 2024, 8 in 2023.

See all prescribing by Dr. Imperiale

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

For MedTech and pharma teams

Find gastroenterologists like Dr. Imperiale by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Thomas F. Imperiale has 111 publications on record

Dmand AI links 111 papers to Dr. Imperiale, published from 2008 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Colorectal Neoplasms, Colonoscopy and Early Detection of Cancer. Dr. Imperiale has published most often in Ann Intern Med. Dr. Imperiale's most frequent co-authors are Charles J. Kahi, MD, Timothy David Imler, MD and David F. Ransohoff, MD.

Papers111
Years published2008 to 2025

Dr. Imperiale's papers by year, 2016 to 2025

Topics Dr. Imperiale writes about most

  • Colorectal Neoplasms
  • Colonoscopy
  • Early Detection of Cancer
  • Mass Screening
  • Adenoma
  • Feces
  • Colonic Polyps
  • Occult Blood

Dr. Imperiale's most frequent co-authors

Recent publications by Dr. Imperiale

See all 111 publications and co-authors

See who Dr. Imperiale researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Imperiale works with, so you can find a warm path to the right gastroenterologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Thomas F. Imperiale has worked on 3 clinical trials

Dmand AI links Dr. Imperiale to 3 clinical trials. Conditions studied include Rectal Diseases and Colorectal Neoplasms. Exact Sciences Corporation sponsors the most, 3.

Conditions in Dr. Imperiale's trials

  • Rectal Diseases
  • Colorectal Neoplasms

Investigators on the most trials with Dr. Imperiale

Recent clinical trials with Dr. Imperiale

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Thomas F. Imperiale received $191,987 in industry payments from 2016 to 2025

CMS Open Payments shows 102 general payments to Dr. Imperiale from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 95% of the total. Exact Sciences Corporation paid the most, $167,372. It also lists 3 research payments totaling $1,103 in 2018.

General payments to Dr. Imperiale by program year, 2016 to 2025

General payments to Dr. Imperiale by kind, 2016 to 2025

$192Kin total
  • Consulting fees$182,96195%
  • Speaker and faculty fees$7,0634%
  • Food and beverage$1,3521%
  • Travel and lodging$5140%
  • Education$990%

Companies that paid Dr. Imperiale the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Imperiale

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Thomas F. Imperiale graduated from New York University School of Medicine

Dr. Imperiale graduated from New York University School of Medicine in 1981.

  1. Medical schoolNew York University School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Thomas F. Imperiale's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Thomas F. Imperiale

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Thomas F. Imperiale's NPI number?

Dr. Thomas F. Imperiale's NPI number is 1427012582. It was assigned on April 14, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Thomas F. Imperiale?

Dr. Thomas F. Imperiale is a gastroenterologist in Batesville, Indiana. The primary specialty in the NPI Registry is Gastroenterology Physician (taxonomy code 207RG0100X).

Where does Dr. Thomas F. Imperiale practice?

Dr. Imperiale practices at 321 Mitchell Avenue, Batesville, IN 47006. Dr. Imperiale's primary practice is Margaret Mary Health Hospice in Batesville, Indiana. Dmand AI also links Dr. Imperiale to 2 group practices and clinics and 2 medical groups.

What is Dr. Thomas F. Imperiale's office phone number?

The practice phone on file for Dr. Imperiale is (812) 933-5125.

What is Dr. Thomas F. Imperiale's medical license number?

Dr. Imperiale holds Indiana license 01045693.

What medical group is Dr. Thomas F. Imperiale part of?

Dr. Imperiale is linked to Margaret Mary Health. Dmand AI links Dr. Imperiale to 2 more medical groups.

Does Dr. Thomas F. Imperiale accept Medicare?

Yes. CMS data shows Dr. Imperiale billed Medicare for 63 services in 2016.

What services does Dr. Thomas F. Imperiale bill to Medicare?

In 2016, Dr. Imperiale's most billed Medicare services were office visit, established patient (99213), surgery: digestive system (45385) and surgery: digestive system (43239).

Where did Dr. Thomas F. Imperiale go to medical school?

Dr. Imperiale graduated from New York University School of Medicine in 1981.

What drugs does Dr. Thomas F. Imperiale prescribe most?

In 2024 Medicare Part D data, Dr. Imperiale's most prescribed drugs by claims were Omeprazole, Sod Sulf-Potass Sulf-Mag Sulf and Linzess.

Show 4 more questionsShow fewer questions

Has Dr. Thomas F. Imperiale received payments from drug or device companies?

CMS Open Payments shows $191,987 in general payments to Dr. Imperiale from 20 companies from 2016 to 2025. The largest total came from Exact Sciences Corporation.

How long has Dr. Thomas F. Imperiale been practicing?

Dr. Imperiale graduated from medical school in 1981, 45 years ago.

Does Dr. Thomas F. Imperiale do research?

Dmand AI links 111 publications to Dr. Imperiale, published from 2008 to 2025. Dr. Imperiale has worked on 3 clinical trials.

Who does Dr. Thomas F. Imperiale publish with?

Dr. Imperiale's most frequent co-authors are Charles J. Kahi, MD (13 shared papers), Timothy David Imler, MD (12 shared papers) and David F. Ransohoff, MD (11 shared papers).

Selling to gastroenterology practices?

See gastroenterologists in Indiana by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)